Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Pluristem Therapeutics, Inc.

   Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Pluristem
                              Therapeutics, Inc.

PR Newswire

NEW YORK, June 4, 2013

NEW YORK, June 4, 2013 /PRNewswire/ --Attorney Advertising -- Bronstein,
Gewirtz & Grossman, LLC is investigating potential claims on behalf of
purchasers of the securities of Pluristem Therapeutics, Inc. ("Pluristem" or
the "Company") (NasdaqCM: PSTI -News). The investigation focuses on whether
the Company and its executives violated federal securities laws.

On Tuesday, June 4, 2013, shares of the Pluristem fell $0.47 or 14% during
intraday trading after the Company said a mid-stage trial of its experimental
muscle pain drug was put on clinical hold by the U.S. Food and Drug
Administration due to a serious allergic reaction in a patient. Out of 74
patients enrolled in Pluristem's trials to date, the Company said this was the
first incident of a serious allergic reaction. The patient was discharged from
the hospital the following day, following the resolution of all her symptoms.
Under a clinical hold, the FDA can suspend or delay an ongoing study and ask
for information from the company.The FDA will issue a letter within the next
30 days detailing a list of questions and requests for information from
Pluristem.

If you are aware of any facts relating to this investigation, or purchased
shares of Pluristem, you can assist this investigation by contacting Peretz
Bronstein, Esq. of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484 or via
email info@bgandg.com. Those who inquire by e-mail are encouraged to include
their mailing address, email and telephone number.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our
primary expertise is the aggressive pursuit of litigation claims on behalf of
our clients. In addition to representing institutions and other investor
plaintiffs in class action security litigation, the firm's expertise includes
general corporate and commercial litigation, as well as securities
arbitration. Attorney advertising. Prior results do not guarantee similar
outcomes.

Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein 212-697-6484
info@bgandg.com

SOURCE Bronstein, Gewirtz & Grossman, LLC

Website: http://www.bgandg.com
 
Press spacebar to pause and continue. Press esc to stop.